{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:00:10Z","timestamp":1777572010602,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fond de la Recherche Scientifique M\u00e9dicale"},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["201502"],"award-info":[{"award-number":["201502"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.vaccine.2013.02.004","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T07:03:04Z","timestamp":1361257384000},"page":"1981-1986","source":"Crossref","is-referenced-by-count":18,"title":["Persistence at one year of age of antigen-induced cellular immune responses in preterm infants vaccinated against whooping cough: Comparison of three different vaccines and effect of a booster dose"],"prefix":"10.1016","volume":"31","author":[{"given":"Fran\u00e7oise","family":"Vermeulen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violette","family":"Dirix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Verscheure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliane","family":"Damis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dani\u00e8le","family":"Vermeylen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Locht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Mascart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2013.02.004_bib0005","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/14760584.3.4.343","article-title":"Developmental immunology and vaccines: immune responses to vaccines in premature infants","volume":"3","author":"Roberton","year":"2004","journal-title":"Exp Rev Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.004_bib0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/pr.2011.26","article-title":"Neonatal T-cell maturation and homing receptor responses to Toll-like receptor ligands differ from those of adult naive T cells: relationship to prematurity","volume":"71","author":"Crespo","year":"2012","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.004_bib0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1542\/peds.112.1.193","article-title":"Immunization of preterm and low birth weight infants","volume":"112","author":"Saari","year":"2003","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.004_bib0020","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1542\/peds.109.3.498","article-title":"Seven-year follow-up of vaccine response in extremely premature infants","volume":"109","author":"Kirmani","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2013.02.004_bib0025","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/adc.2004.052720","article-title":"DT5aP-Hib-IPV and MCC vaccines: preterm infants response to accelerated immunization","volume":"90","author":"Slack","year":"2005","journal-title":"Arch Dis Child"},{"issue":"8592","key":"10.1016\/j.vaccine.2013.02.004_bib0030","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(88)91778-3","article-title":"Placebo-controlled trial of two acellular pertussis vaccines in Sweden-protective efficacy and adverse events","volume":"1","author":"Ad Hoc Group for the Study of Pertussis Vaccines","year":"1988","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2013.02.004_bib0035","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine","volume":"334","author":"Gustafsson","year":"1996","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2013.02.004_bib0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM199602083340601","article-title":"A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group","volume":"334","author":"Greco","year":"1996","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2013.02.004_bib0045","doi-asserted-by":"crossref","first-page":"e10178","DOI":"10.1371\/journal.pone.0010178","article-title":"T.- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis","volume":"5","author":"Feunou","year":"2010","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2013.02.004_bib0050","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1086\/315527","article-title":"Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children","volume":"181","author":"Mahon","year":"2000","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.004_bib0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/IAI.61.2.399-410.1993","article-title":"Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model","volume":"61","author":"Mills","year":"1993","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.004_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2567.1998.00401.x","article-title":"Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children","volume":"93","author":"Ryan","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2013.02.004_bib0065","doi-asserted-by":"crossref","first-page":"795958","DOI":"10.1155\/2012\/795958","article-title":"Both CD4+ and CD8+ lymphocytes participate in the IFN-\u03b3 response to filamentous hemagglutinin from Bordetella pertussis in infants, children, and adults","volume":"2012","author":"Dirix","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.004_bib0070","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.4049\/jimmunol.170.3.1504","article-title":"Bordetella pertussis infection in 2-month-old infants promotes type 1T cell responses","volume":"170","author":"Mascart","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.02.004_bib0075","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archpedi.1997.02170400069013","article-title":"Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines","volume":"151","author":"Cassone","year":"1997","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2013.02.004_bib0080","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1128\/IAI.67.8.4064-4071.1999","article-title":"Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines","volume":"67","author":"Ausiello","year":"1999","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.004_bib0085","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1128\/CVI.00328-09","article-title":"Cellular immune responses of preterm infants after vaccination with whole-cell or acellular pertussis vaccines","volume":"17","author":"Vermeulen","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"43","key":"10.1016\/j.vaccine.2013.02.004_bib0090","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1016\/j.vaccine.2009.07.075","article-title":"Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy","volume":"27","author":"Dirix","year":"2009","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2013.02.004_bib0095","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/INF.0b013e318124a9c8","article-title":"Antibody persistence and booster vaccination during the second and fifth years of life in a cohort of children who were born prematurely","volume":"26","author":"Ome\u00f1aca","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2013.02.004_bib0100","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1651-2227.2008.00884.x","article-title":"Immunogenicity and reactogenicity of DTPa-HBV-IPV\/Hib vaccine as primary and booster vaccination in low-birth-weight premature infants","volume":"97","author":"V\u00e1zquez","year":"2008","journal-title":"Acta Paediatr"},{"issue":"6","key":"10.1016\/j.vaccine.2013.02.004_bib0105","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1128\/IAI.58.6.1518-1526.1990","article-title":"Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin","volume":"58","author":"Antoine","year":"1990","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.004_bib0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1574-6968.1991.tb04417.x","article-title":"Interaction of the Bordetella pertussis filamentous hemagglutinin with heparin","volume":"78","author":"Menozzi","year":"1991","journal-title":"FEMS Microbiol Lett"},{"issue":"10","key":"10.1016\/j.vaccine.2013.02.004_bib0115","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.1128\/IAI.69.10.6038-6043.2001","article-title":"Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection","volume":"69","author":"Alonso","year":"2001","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.004_bib0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/biol.1998.9999","article-title":"Dose-response to a two-component acellular pertussis vaccine in infants and comparison with whole-cell vaccine","volume":"26","author":"Auerbach","year":"1998","journal-title":"Biologicals"},{"issue":"17","key":"10.1016\/j.vaccine.2013.02.004_bib0125","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0264-410X(98)00060-7","article-title":"The preterm infant's antibody response to a combined diphtheria, tetanus, acellular pertussis and hepatitis B vaccine","volume":"16","author":"Faldella","year":"1998","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2013.02.004_bib0130","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1542\/peds.103.5.e60","article-title":"Safety and immunogenicity of an acellular pertussis vaccine in premature infants","volume":"103","author":"Schloesser","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2013.02.004_bib0135","doi-asserted-by":"crossref","unstructured":"Combination vaccines for childhood immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP). Pediatrics 1999;103:1064\u201377.","DOI":"10.1542\/peds.103.5.1064"},{"issue":"6","key":"10.1016\/j.vaccine.2013.02.004_bib0140","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1586\/erv.09.32","article-title":"Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV\/Hib hexavalent vaccine)","volume":"8","author":"Zepp","year":"2009","journal-title":"Exp Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.004_bib0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1586\/14760584.6.1.47","article-title":"Acellular pertussis vaccines and the role of pertactin and fimbriae","volume":"6","author":"Poolman","year":"2007","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.02.004_bib0150","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1016\/j.vaccine.2010.01.010","article-title":"Th2-polarisation of cellular immune memory to neonatal vaccination","volume":"28","author":"White","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.004_bib0155","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.vaccine.2006.06.046","article-title":"Modulation of the infant immune responses by the first pertussis vaccine administrations","volume":"25","author":"Mascart","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2013.02.004_bib0160","doi-asserted-by":"crossref","first-page":"e717","DOI":"10.1542\/peds.2005-0348","article-title":"Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria\/tetanus\/acellular pertussis\/Hib combination vaccine, significant prematurity, and a fourth dose","volume":"117","author":"Berrington","year":"2006","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.004_bib0165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00005-006-0020-4","article-title":"Haemophilus influenzae type b and pertussis vaccinations in preterm infants","volume":"54","author":"Sikora","year":"2006","journal-title":"Arch Immunol Ther Exp"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13001576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13001576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T16:19:31Z","timestamp":1688055571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13001576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":33,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0264410X13001576"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.02.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}